Evidence map›Paper›PMID 28274044›Full record

ArticleJournal of clinical and diagnostic research : JCDR2017

Increased Advanced Oxidation Protein Products Generation by Cyclosporine-A and Angiotensin II in Human Gingival Fibroblasts - Ex-vivo Study.

Suresh Ranga Rao, Rajasekaran Subbarayan, Supraja Ajitkumar, Dinesh Murugan Girija

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical and diagnostic research : JCDR, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Suresh Ranga RaoHead of Department, Department of Periodontics, Sri Ramachandra University , Chennai, Tamil Nadu, India .
Rajasekaran SubbarayanResearch Scholar, Centre for Regenerative Medicine and Stem Cell Research, Central Research Facility, Sri Ramachandra University , Chennai, Tamil Nadu, India .
Supraja AjitkumarLecturer, Department of Periodontics, Sri Ramachandra University Chennai , Tamil Nadu, India .
Dinesh Murugan GirijaResearch Scholar, Centre for Indian Systems of Medicine Quality Assurance and Standardization, Sri Ramachandra University , Chennai, Tamil Nadu, India .
Sri Ramachandra Institute of Higher Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCyclosporin-A (CsA), an immunosuppressant, induces renal fibrosis and Renin Angiotensin System (RAS) is known to play a major role. CsA has the potential to increase the oxidative stress; specifically through the Advanced Oxidation Protein Products (AOPP) which could possibly stimulate fibrosis. A similar type of pathology occurs even in the gingiva known as CsA Induced Gingival Overgrowth (CIGO).

aimThis study was undertaken to estimate the AOPP generation by Human Gingival Fibroblasts (HGF) under the influence of CsA and Angiotensin II (Ang II). MATERIALS AND

methodsSix healthy gingival tissue samples were obtained during crown lengthening procedure and primary HGF were cultured using enzymatic digestion method. The ideal non-cytotoxic concentrations of CsA and Ang II were identified using cytotoxicity assay. Later, HGF were incubated with CsA and Ang II for 12 hours and AOPP assay was performed at zero and one hour interval.

resultsThere was a statistically significant increase in AOPP production in both the CsA and Ang II when compared to the control group with a p value<0.05.

conclusionCsA can induce oxidative stress and preventing/controlling it may be necessary to prevent untoward effect of the drug.

Indexed as

Oxidative stressReactive oxygen speciesRenin angiotensin system

Identifiers

PMID28274044
PMCPMC5324495
OpenAlexW2588835456

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.